Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAS41004 versus Daivobet ointment in mild to moderate plaque psoriasis
2013-003757-22Phase 2Completed
- Sponsor
- Almirall
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of LAS41004 IMP5 and calcipotriol + betamethasone in plaque psoriasis (2 arms), sponsored by Almirall. Started Jan 2014; status: completed.
02
Drugs
LAS41004 IMP5calcipotriol + betamethasone
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2013-003757-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003757-22.